BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

BMEDvsXLVIETF Comparison

ETF 1

BMED

iShares Health Innovation Active ETF

This fund is part of

Healthcare Technology

-0.16%

Full BMED fund page

VS

ETF 2

XLVI

State Street Health Care Select Sector SPDR Premium Income Fund

This fund is part of

Options Strategies

-0.63%

Full XLVI fund page

iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) is part of the Options Strategies segment. BMED's top 3 sector exposures are Healthcare and Non-Corporate. In contrast, XLVI's top sector exposures are Healthcare and Consumer Non-Cyclicals. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.35% for XLVI. BMED is up 1.48% year-to-date (YTD) with +$4M in YTD flows. XLVI performs better with 5.93% YTD performance, and +$7M in YTD flows. Run a side-by-side ETF comparison of BMED and XLVI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

BMED vs XLVI performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 07/17/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	BMED XLVI	+7.90%+4.74%	+4.20%+7.42%	+1.48%+5.93%	+23.30%n/a	+23.27%n/a	+4.16%n/a
Flows	BMED XLVI	-+$3M	-+$5M	+$4M+$7M	+$6M-	+$4M-	+$5M-

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	BMED XLVI	+17.48%+12.46%	+15.99%n/a	+16.00%n/a	+17.71%n/a
Max drawdown	BMED XLVI	-7.61%-3.10%	-14.71%n/a	-19.76%n/a	-33.96%n/a
Max drawdown duration	BMED XLVI	65d29d	176dn/a	237dn/a	1586dn/a

Trading data

Create an account to view trading data

Join for free

	BMED	XLVI
Last sale 7/17/2026 at 1:30 PM	$30.65	$26.27
Previous close 07/16/2026	$30.80	$26.38
Consolidated volume 07/16/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Main metrics

Last update 7/17/2026 at 1:30 PM

Live

Closed

	BMED	XLVI
Last price	$30.65	$26.27
1D performance	-0.49%	-0.41%
AuM	$11.03 M	$18.39 M
E/R	0.77%	0.35%

Characteristics

	BMED	XLVI
Management strategy	Active	Active
Provider	iShares	State Street Investment Management
Benchmark	-	-
N° of holdings	51	59
Asset class	-	-
Trailing 12m distribution yield	Join	Join
Inception date	September 29, 2020	July 30, 2025
ESG	No	No

More BMED data on Trackinsight

More XLVI data on Trackinsight

Exposure

Countries

BMED

USA

83.2%

Other

16.8%

XLVI

USA

97.67%

Other

2.33%

Sectors

BMED

Healthcare

94.88%

Other

5.12%

XLVI

Healthcare

97.66%

Other

2.34%

Diversification

BMED

Total weight of top 15 holdings out of 15

57.26%

XLVI

Total weight of top 15 holdings out of 15

71.91%

Top 15 holdings

Data as of May 31, 2026

BMED

Gilead Sciences, Inc.

5.42%

Merck & Co., Inc.

5.17%

Johnson & Johnson

5.15%

Edwards Lifesciences Corp.

4.79%

BlackRock Cash Funds - Treasury

4.74%

Waters Corp.

3.84%

Biogen, Inc.

3.67%

Bruker Corp.

3.64%

Amgen, Inc.

3.41%

WuXi Biologics (Cayman), Inc.

3.13%

Charles River Laboratories International, Inc.

3.12%

Vertex Pharmaceuticals, Inc.

2.99%

Mettler-Toledo International, Inc.

2.80%

Danaher Corp.

2.77%

Moderna, Inc.

2.65%

XLVI

Eli Lilly & Co.

16.21%

Johnson & Johnson

10.05%

AbbVie, Inc.

7.12%

UnitedHealth Group, Inc.

6.38%

Merck & Co., Inc.

5.45%

Thermo Fisher Scientific, Inc.

3.42%

Amgen, Inc.

3.36%

Gilead Sciences, Inc.

3.09%

Intuitive Surgical, Inc.

2.79%

Pfizer Inc.

2.76%

Abbott Laboratories

2.75%

Bristol Myers Squibb Co.

2.16%

CVS Health Corp.

2.14%

Danaher Corp.

2.13%

Vertex Pharmaceuticals, Inc.

2.10%

Frequently asked questions about BMED and XLVI

How have the BMED and XLVI ETFs performed in 2026?

As of July 17, 2026, BMED is up 1.48% year-to-date (YTD), while XLVI has returned 5.93%. That puts XLVI better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or XLVI?

Year-to-date, the BMED ETF saw +$4M in flows, compared to +$7M for XLVI.

Which ETF is bigger: BMED or XLVI?

As of July 17, 2026, BMED holds $11.03 M in assets under management (AUM), while XLVI manages $18.39 M.

What sectors do the BMED and XLVI ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, XLVI focuses on Healthcare.

What are the top holdings of the BMED ETF and XLVI ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and Johnson & Johnson. XLVI holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

BMEDvsXLVIETF Comparison

iShares Health Innovation Active ETF

State Street Health Care Select Sector SPDR Premium Income Fund

BMED vs XLVI performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the BMED and XLVI ETFs performed in 2026?

As of July 17, 2026, BMED is up 1.48% year-to-date (YTD), while XLVI has returned 5.93%. That puts XLVI better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or XLVI?

Year-to-date, the BMED ETF saw +$4M in flows, compared to +$7M for XLVI.

Which ETF is bigger: BMED or XLVI?

As of July 17, 2026, BMED holds $11.03 M in assets under management (AUM), while XLVI manages $18.39 M.

What sectors do the BMED and XLVI ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, XLVI focuses on Healthcare.

What are the top holdings of the BMED ETF and XLVI ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and Johnson & Johnson. XLVI holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: BMED or XLVI?

BMED holds 54 securities with 57.26% of its assets in the top 15. XLVI has 59 securities and a top 15 weight of 71.91%.

Build and Analyze Your ETF Portfolio Like a Pro